• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- VID in US ebbs further; WHO weighs in on virus-source controversy

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/covid-19/covid-us-ebbs-further-who-weighs-virus-source-controversy

VID in US ebbs further; WHO weighs in on virus-source controversy


Lisa Schnirring

25 minutes ago.

COVID-19
US COVID-19 indicators continue a gradual downward trend, with proportions of the Omicron XBB.1.5 variant steadily rising, the Centers for Disease Control and Prevention (CDC) said today in its latest updates.

In international developments, the head of the World Health Organization (WHO) today called on all countries with knowledge about the origin of SARS-CoV-2 to share details with the WHO and the international science community, while reiterating that the WHO continues to push for studies into the origins.

COVID markers fall, but more than 300 die each day

It its biweekly data synopsis, the CDC said the 7-day average for new daily COVID-19 cases is 32,374, down 5.1% compared to the previous week. The daily average for new hospitalizations as of the last week of February was 3,318, a decrease of 7.9% compared to the week before.

An average of 338 people die from COVID-19 each day, reflecting a drop of 3.3% compared to the week before, the CDC said.

Meanwhile, in the latest Omicron variant proportion estimates, the CDC said XBB.1.5 makes up 89.6% of cases, up from 85.4% last week. No other variant showed increasing proportions. The subvariant has been dominant in all US regions over the past few weeks.

WHO weighs in on virus origin controversy

At a media briefing today, WHO Director-General Tedros Adhanom Ghebreyesus, PhD, addressed renewed interest in the origin of SARS-CoV-2 amid assessments, without details, from two US government agencies that the virus likely came from a lab accident.

He said it's important to share what led to the findings, not to assign blame but to better understand how the pandemic began, a key part of preventing and preparing for the next one.

Tedros said the WHO's Scientific Advisory Group for the Origins of Novel Pathogens has spelled out the studies that need to be done, and he said he continues to press China to conduct the probes and share the results.

"Until then, all hypotheses on the origins of the virus remain on the table," he said, adding that political wrangling has made the task of identifying the source more difficult.

All hypotheses on the origins of the virus remain on the table.

In other global developments, COVID-19 activity is rising in a number of European countries, with serious cases and deaths also increasing, the European Centre for Disease Prevention and Control (ECDC) said today in its weekly update. It said XBB.1.5 is now the most frequently detected subvariant, making up 33.8% of cases. Other subvariants still make up substantial proportions, including BQ.1 at 26.8% and BA.2.75 at 22.2%.

In a separate statement, the ECDC said it de-escalated BA.2, BA.4, and BA.5 as variants of concern, because the parental lineages are no longer circulating. Currently, there are no variants of concern on the list, a sign that the epidemiologic situation is currently stable, the group added.

The ECDC has four subvariants of interest on its list, including BQ.1, BA.2.75, XBB, and XBB.1.5.
 
Back
Top Bottom